Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / @xirurgi_2025 / @xirurgi_2025 - 468 - файл

.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
33 Мб
Скачать
324
https://t.me/medicina_free
V. A. Manon et al.
Introduction
Continuous advances in surgical techniques and immunotherapies are anticipated to improve survival rates of patients with head and neck cancer, placing even greater emphasis on maxillofacial reconstruction by surgeons. While much of this attention has been directed toward the restoration of muscular and bony structures, increased patient longevity has directed focus toward the reconstruction of resected nerves fol­lowing resection of pathology. The purpose of this review was to discuss the impact of inferior alveolar nerve (IAN) and/or lingual nerve (LN) resection on quality of life and examine the numerous reconstructive options now available to practitioners.
Methods
A literature review was conducted to determine the qualitative and quantitative effects of IAN and/or LN resection on quality of life (QoL), using scales such as the Medical Research Council Scale (MRCS) and/or the Oral Health Impact Questionnaire (OHIP). We also searched for data regarding the relationship of time to nerve reconstruction and improvement in functional sensory recovery and overall QoL.In accord with the policy of the institutional review board of the University of Texas Health Sciences Center at Houston (UTHealth), institutional review board approved of this study.
Results
Persistent paresthesia and/or anesthesia of the IAN or LN results in signicantly reduced quality of life with psychosocial and physical implications. Patients report interferences in their ability to socialize (i.e., retaining food particles on the face or drooling) and difculties with employment. Other psychological implications include increased social anxiety and symptoms of clinical depression. When addressed within 9months of injury or resection, reconstruction of the inferior alve­olar and/or lingual nerves via direct neurorrhaphy, autografts, or processed alloge­neic grafts has successfully demonstrated marked improvements in patients’ functional sensory recovery and overall quality of life.
Conclusion
The results of this review indicate that timely reconstruction of the inferior alveolar and/or lingual nerves can lead to signicant improvements in functional sensory recovery and patient quality of life. When reviewing options for reconstruction of maxillomandibular and oral structures, consideration of nerve reconstruction should also be prioritized.
18 The New Norm: Examining Quality of Life with Trigeminal Nerve Decits and…
https://t.me/medicina_free
325
Background
The inferior alveolar (IAN) and lingual (LN) nerves are branches of the mandibular nerve, the third branch of the trigeminal nerve (cranial nerve V). When functioning normally, the IAN provides sensation to the lower teeth and lip, while the LN pro­vides general sensory innervation to the anterior two-thirds of the tongue. Upon exiting the mandible at the mental foramen, the IAN continues as the mental nerve providing sensation to the front of the chin and lower lip. These functions facilitate daily activities such as chewing, smiling, and tasting, which play an important role in social interactions. Damage to the IAN or LN during surgery can result in anes­thesia or paresthesia of the affected structures, therefore interfering with daily activ­ities and the patient’s quality of life. Injury of these structures occurs most commonly during lower third molar extractions, but certain procedures, such as mandibular resections for benign or malignant pathology, may also require the resection of these nerves. While reconstruction of bone and soft tissue defects has been exten­sively studied and is a common procedure for most oral surgeons, reconstruction of the nerves is less common and not always considered by surgeons, which can leave patients with persistent functional sensory decits.
Various techniques are available to the surgeon for reconstruct of the IAN and/or LN; if possible, nerve reconstruction should be implemented during the primary reconstruction, particularly after mandibular resections for benign and malignant head and neck pathology. As advances are made in surgery, chemoradiation, and now immunotherapy, patient survival rates for head and neck cancer have increased from 53% in the 1970s to 66% in 2010 [1]. Surgical management of benign and malignant pathology of the maxillomandibular region includes resection of the affected structures, often including the IAN and LNs. Improvements in survival rates have motivated surgeons and their patients to pursue additional surgeries to reconstruct the residual defects. This should include reconstruction of the resected neural structures to improve the surviving patients’ quality of life. While direct neu­rorrhaphy can be used for nerve transections where nerve stumps are in close prox­imity, this requires approximation of the free nerve stumps without tension and is not feasible for larger spanning defects. Autogenous grafts, commonly requiring harvest of the sural nerve, may be successfully used in younger patients but can result in donor site morbidity, including the additional surgical site and sensory de­cits in the distribution of the harvested nerve. Decellularized allogenic nerve grafts, such as the AxoGen AVANCE graft, can be used to successfully reconstruct neural defects over distances of 5–70mm without tension, donor site morbidity, or immu­nosuppression. Nerve reconstruction techniques have demonstrated greater func­tional sensory recovery (FSR) with early intervention as compared to delayed or no intervention. Patients that do not receive early intervention often report persistent neurosensory disturbances, affecting their overall quality of life [26]. While early intervention is advocated over delayed intervention, Robinson etal. found that there was no correlation in outcome measures and timing of repair for lingual nerve inju­ries [7]. Instead they found that early or delayed intervention did not reduce the
326
https://t.me/medicina_free
Table 18.1 Medical Research Council Scale (MRCS) for neurosensory recovery
Score Parameter FSR
S0 No recovery No S1 Recovery of deep cutaneous pain No S1+ Recovery of some supercial pain No S2 Recovery of some supercial pain and tactile
sensation S2+ S2 with over-response No S3 S2+ without over-response and 2-PD >15mm Yes, clinical recovery S3+ S3, plus 2-PD=7–15mm Yes S4 S3+, plus 2-PD=2–6mm Yes, complete recovery
No
V. A. Manon et al.
number of patients with dysesthesia, but reduced the quality of their symptoms. Patients that do not receive surgical intervention often report persistent neurosen­sory disturbances, affecting their overall quality of life.
Patients with residual decits of the IAN and/or LN consistently report higher levels of dissatisfaction and poorer quality of life. Objective measures of functional sensory recovery include neurosensory testing instruments and survey. The Medical Research Council Scale (MRCS) is commonly used, although this measure does not assess the patient’s self-perceptions of quality of life or impact on daily activities. The MRCS uses neurosensory tests, such as two-point discrimination, brushstroke directional sensation, contact detection, and pain and temperature nociception, and scores the recovery on a scale from S0 to S4 (Table18.1) [8, 9]. While these mea­sures are crucial for the evaluation, documented measurements of the patients’ sub­jective experiences are less likely to be collected and discussed. Other methods can be used to assess subjective sensory recovery, such as surveys or the visual analogue scale (scale, 0–10, with 0 = completely anesthetic and 10 = normal sensation). Various surveys have been designed and can be used to collect this information; the Oral Health Impact Questionnaire (OHIP) and Short Form Health Survey (SF-36) are widely used today [10, 11]. The OHIP, originally developed by Slade in 1977, is a 49-question survey used to evaluate the patient’s perceptions of their functional disability, physical pain, physical disability, psychological disability, social disabil­ity, psychological discomfort, and handicap. The OHIP-14 is an abbreviated, 14-question version of the OHIP.The SF-36 can be used to measure health-related quality of life using eight subcategories of physical and mental components. The physical component score (PCS) includes physical functioning, role-physical, bodily pain, and general health. The mental component score (MCS) includes patient perceptions of vitality, social functioning, role-emotional, and mental health. These scores quantify the patients’ self-perceptions of physical and mental health­related quality of life [12]. Patients with persistent neurosensory disturbances evalu­ated using the OHIP and/or SF-36 after IAN and/or LN damage are found to report consistently higher levels of dissatisfaction in each category. These studies demon­strate that these patients have poorer quality of life as compared to those that do not have these neurosensory disturbances [1012].
18 The New Norm: Examining Quality of Life with Trigeminal Nerve Decits and…
https://t.me/medicina_free
The purpose of this paper is to discuss the decreased quality of life observed in patients with IAN and LN neurosensory disturbances and encourage practitioners to consider neural reconstruction in the effort to improve the lives of their patients. Advances in the management of head and neck cancer have increased the survival rates of patients requiring major resections of the mandible and associated neural structures, and this improvement has led to the need for reconstruction of the patient’s maxillomandibular defects. Failure to reconstruct the patient’s IAN and/or LN leads to persistent neurosensory disturbances, reducing the patient’s quality of life. When possible, immediate reconstruction of the nerves should be seriously considered during surgical planning. The surgeon should be aware of the psychoso­cial impact nerve decits can have and should discuss this, as well as treatment options, with the patient.
327
Review ofLiterature
How Does This Problem Impact andAffect theAficted Population andHow Can It BeMeasured?
Patients with persistent neurosensory disturbances after IAN and/or LN damage consistently report reduced quality of life related to their injuries. When evaluated using the OHIP-14 and/or SF-36, patients consistently report more functional/phys­ical limitations and psychological discomfort and disabilities as compared to those that did not suffer the same injury [1012]. Reported functional/physical limitations include difculty eating, speech deterioration, inability to detect food on the lip when eating, and unawareness of drooling [12, 13]. Negative impacts of these phys­ical limitations have social implications including the patients’ ability to socialize with others, their ability to enjoy their food, and their difculties with employment [12, 14]. The psychosocial implications of these difculties can impact the patients’ self-perceptions, leading to increased social anxiety, difculty managing emotions of anger and irritability, and even clinical depression [10, 14]. While neurosensory recovery is an important parameter to record when these injuries occur, understand­ing the patients’ physical and psychological disabilities that resulted from this injury is equally as important to understand and document.
The surgeon’s ability to elicit and discuss the aforementioned problems can help them properly inform the patient of complications associated with IAN and/or LN injury prior to surgery and to manage the aficted patient postoperatively. Patel etal. conducted interviews with ve aficted patients, nding many were dissatis­ed with the initial consent process, their injury, and postoperative management [12]. Many questioned the informed consent process and stated they felt they were not properly informed of the quality of life implications associated with neural dam­age. They expressed a desire for more information preoperatively and on the recov­ery prognosis. This indicates a need for a more comprehensive, preoperative
328
https://t.me/medicina_free
discussion regarding the impact on quality of life that neurosensory decits can cause. Many also expressed signicant frustration and anger associated with the injury, indicating that they felt they were not appropriately managed initially after the injury. Patel et al. found that the average time of referral to a specialist was 7months postoperatively (range 3weeks to 18months). Patients indicated that they would like disclosure of their neurosensory prognosis and prompt management. Given the physical and psychosocial implications of these injuries, there is a need to improve postoperative management, including early referral to a specialist, surgical intervention, and management of patient expectations [12, 15, 16]. In accord with the policy of the institutional review board of the University of Texas Health Sciences Center at Houston (UTHealth), institutional review board approved this study.
V. A. Manon et al.
Available Surgical Interventions
Surgical intervention of neural injuries is critical for improvement of functional sensory recovery and improvement of quality of life. Once the surgeon identies a nerve injury or knows that treatment will require transection of neural structures, prompt initial management is necessary for clinical success and patient satisfaction [27]. Indications for trigeminal nerve repair include observed nerve transection, lack of clinical improvement of paresthesia for >3months, development of neuropa­thy due to nerve entrapment or neuroma formation, presence of a foreign body, worsening paresthesia or dysesthesia, and hypoesthesia affecting patient’s quality of life [3]. Techniques for neural repair or reconstruction include direct neurorrha­phy, autogenous nerve grafts, vascularized free aps, and decellularized allogenic nerve grafts.
Direct neurorrhaphy is the direct repair of the proximal and distal nerve stumps. The most commonly used method for direct nerve repair of the IAN or LN is the epineural suture technique. Successful surgical outcomes, dened as return of use­ful sensory function, are best achieved with timely repair (within 9months from the time of injury) and tension-free approximation of the nerve ends. In a retrospective study of 222 lingual nerve repairs, Bagheri et al. found that 90.5% of patients achieved useful sensory recovery or complete return of sensation with use of this technique [2]. Patients that sought surgical intervention after 9months were signi­cantly less likely to achieve any meaningful sensory recovery. The study also found that age and preoperative symptoms were important determinants of surgical suc­cess. For every year above the age of 45, the chances of obtaining functional sensory recovery decreased 5.5%; preoperative numbness, as compared to preoperative pain, was a negative indicator for return of sensation.
Autogenous nerve grafting, considered the gold standard for peripheral nerve grafting, allows tension-free approximation when larger defects are present [17,
18]. The surgeon must consider the following factors when determining the choice
of a donor nerve graft: accessibility, length required, diameter of donor nerve
18 The New Norm: Examining Quality of Life with Trigeminal Nerve Decits and…
https://t.me/medicina_free
329
compared to host nerve, patient reference, and fascicular number and pattern. The two most commonly used autogenous nerve grafts are the sural and great auricular nerves (GAN). There is some debate as to the appropriate length for the use of cer­tain nerve grafts. The great auricular nerve in the upper lateral neck has been the most frequently harvested for nerve defects of less than 3cm, while the sural nerve in the lower extremity is more suitable for longer nerve defects [19]. Wolford rec­ommends that the GAN should only be used to reconstruct defects up to 1.5cm in length and that the sural nerve should be used for defects up to 2.5cm [17, 19]. Although the graft can successfully be used to create a tension-free nerve repair, it can be difcult to achieve ideal donor to recipient match and is associated with donor site morbidity [17]. Despite harvesting the nerve from a donor site, Miloro and Stoner found that most patients under the age of 38 tolerated harvest of the sural nerve without signicant neurosensory disturbances or morbidity of the donor site if functional sensory recovery was achieved at the trigeminal nerve [20].
Microvascular free tissue transfer offers great versatility in the selection of tissue for reconstruction of head and neck defects. The utilization of vascularized free aps is indicated when extensive soft tissue and bone are included in tumor ablation or an avulsive injury that requires reconstruction. The nerves contained in the fol­lowing vascularized free aps may be used for nerve repair:
• The medial antebrachial [21] or the lateral cutaneous nerve of forearm [22]. In a
study of 22 patients who had glossectomy for oral carcinoma, Kuriakose found
that 77% of patients had sensory recovery within 8months after reconstruction
with a radial forearm free ap via the lateral antebrachial cutaneous nerve [23].
• The long thoracic nerve can be harvested when performing a scapula latissimus
dorsi free ap. Schultes etal. found that all ve patients had progressive return
of sensation when the long thoracic nerve was used to reconstruct the mental
nerve [24]. Pressure sensation returned for the ve patients at 3–4months post-
operatively. Pain sensation returned thereafter 2 months, with conversion to
hyperesthesia, lessening to normal after months 5 and 6. Four of the ve patients
were able to discriminate between sharp and blunt sensations after the fth
month, the last patient after 7months. At 6–7months, all patients were able to
discriminate between two points and recovered senses of vibration and light
touch in the original region of the mental nerve distribution. After 9months, four
patients had bilateral equal sensitivity.
• A case report by Tanaka etal. found that the lateral sural cutaneous nerve can be
anastomosed to the distal end of the remnant lAN using an epineural repair [25].
The mandible was reconstructed with a bula free ap that included the sural
nerve. The proximal ends of the right and left IAN were re-approximated to the
proximal and distal ends of the sural nerve. Sensations were measured using
Semmes-Weinstein monolaments. Tanaka et al. found that sensory recovery
was rst noted after 5 months and the quantitative results of the Semmes-
Weinstein test 45months after surgery ranged from 2.83 to 4.08.
Nerve allografts are decellularized conduits that serve as a temporary scaffold for neural regeneration [26]. The decellularized allogenic nerve graft provides an
330
https://t.me/medicina_free
unlimited source of graft with no associated donor site morbidity and reduces the risk of immune rejection [17, 27]. Processed nerve allografts may be safely and effectively used to reconstruct trigeminal sensory nerve defects between 5 and 70mm. Miloro etal. found that patients that had reconstruction of the IAN or LN with allogeneic grafts reported a satisfaction score of 8.9 on the visual analogue scale, as compared to the reported score of 8.1 for patients that had undergone direct repair. He also reported an accelerated rate of functional sensory recovery as com­pared to direct neurorrhaphy or no intervention [28]. The study noted that indirect graft nerve repair, using an allograft (AVANCE nerve graft), is associated with improved objective and subjective nerve outcomes compared with direct nerve repair [28]. Zuniga also reported that of his 16 patients reconstructed with an allo­geneic nerve graft, 14 (87%) of them saw improvements in sensory function (87%) [29]. Salomon reported a similar nding, stating that 85.7% of his patients recon­structed with the allogeneic nerve graft achieved some return of tactile sensation and supercial pain without over-response [9]. Numerous publications have con­rmed the safety and efcacy of using a cadaveric peripheral nerve allograft (AVANCE, Axogen Corporation, Alachua, FL) to reconstruct the inferior alveolar nerve (IAN) following non-ablative and ablative mandibular resection, mostly for benign disease [1, 2830]. Risks associated with the reconstruction include failure to gain FSR; this approach is not associated with the donor site morbidity of autolo­gous nerve grafts. It is important to note that even if only some sensation is regained, this would be an improvement as opposed to no attempt at nerve reconstruction and, consequently, no change in neurosensory function [17, 31]. It has been proposed that acellular processed nerve allografts may replace autogenous nerve grafts [30].
V. A. Manon et al.
Conclusions
Iatrogenic injury or resection of the IAN and/or LNs as a result of oral and maxil­lofacial procedures can result in devastating physical and psychosocial complica­tions for the patient, reducing their overall quality of life. These injuries can negatively impact the patients’ ability to eat and enjoy their food and impair social interactions via deterioration of speech, sensory limitations causing retention of food on the face and drooling, and increased self-conscious awareness associated with their disabilities. Psychological consequences of these impairments may lead to clinical depression. It is imperative that these potential complications and their associated functional/sensory implications are discussed preoperatively and that they are managed promptly and appropriately when they occur. Attention to the patient’s psychosocial and functional disabilities deserves attention in order to achieve holistic patient care.
Surgeons are encouraged to document functional sensory loss after these injuries and perceived quality of life using patient surveys such as the OHIP-14 or SF-36. Once physical and/or psychological disabilities are observed and documented, prompt intervention or referral is crucial for successful clinical outcomes and patient
18 The New Norm: Examining Quality of Life with Trigeminal Nerve Decits and…
https://t.me/medicina_free
331
satisfaction. Various treatment options are available to the head and neck surgeon: direct neurorrhaphy, autogenous nerve grafts, vascularized free aps, and decellu­larized allogenic nerve grafts. Use of these techniques can result in signicant func­tional sensory recovery, improving the patients’ overall quality of life. When possible, the surgeon is encouraged to consider maxillomandibular reconstruction not only of the bone and soft tissues but also of the sensory nerves necessary for human function.
References
1. Tursun R, Green JM III.Immediate microsurgical bone and nerve reconstruction in the irradi­ated patient: a case report. J Oral Maxillofac Surg. 2017;75(6):1302.e1301–7.
2. Bagheri SC, etal. Retrospective review of microsurgical repair of 222 lingual nerve injuries. J Oral Maxillofac Surg. 2010;68(4):715–23.
3. Ziccardi VB.Microsurgical techniques for repair of the inferior alveolar and lingual nerves. Atlas Oral Maxillofac Surg Clin North Am. 2011;19(1):79–90.
4. Bagheri SC, etal. Microsurgical repair of the inferior alveolar nerve: success rate and factors that adversely affect outcome. J Oral Maxillofac Surg. 2012;70(8):1978–90.
5. Erakat MS, etal. Interval between injury and lingual nerve repair as a prognostic factor for success using type I collagen conduit. J Oral Maxillofac Surg. 2013;71(5):833–8.
6. White H, Rosenthal E.Static and dynamic repairs of facial nerve injuries. Oral Maxillofac Surg Clin North Am. 2013;25(2):303–12.
7. Robinson PP, etal. Current management of damage to the inferior alveolar and lingual nerves as a result of removal of third molars. Br J Oral Maxillofac Surg. 2004;42(4):285–92.
8. Doucet JC, etal. Concomitant removal of mandibular third molars during sagittal split oste­otomy minimizes neurosensory dysfunction. J Oral Maxillofac Surg. 2012;70(9):2153–63.
9. Salomon D, etal. Outcomes of immediate allograft reconstruction of long-span defects of the inferior alveolar nerve. J Oral Maxillofac Surg. 2016;74(12):2507–14.
10. Leung YY, etal. Trigeminal neurosensory decit and patient reported outcome measures: the effect on quality of life. PLoS One. 2013;8(10):e77391.
11. Cakir M, etal. Effects of inferior alveolar nerve neurosensory decits on quality of life. Niger J Clin Pract. 2018;21(2):206–11.
12. Patel N, etal. Quality of life following injury to the inferior dental or lingual nerve– a cross­sectional mixed-methods study. Oral Surg. 2018;11(1):9–16.
13. Sandstedt P, Sorensen S.Neurosensory disturbances of the trigeminal nerve: a long-term fol­low- up of traumatic injuries. J Oral Maxillofac Surg. 1995;53(5):498–505.
14. Pogrel MA, etal. Long-term outcome of trigeminal nerve injuries related to dental treatment. J Oral Maxillofac Surg. 2011;69(9):2284–8.
15. Tolle T, etal. Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in six European countries. Pain Pract. 2006;6(3):153–60.
16. Smith JG, etal. The psychosocial and affective burden of posttraumatic neuropathy following injuries to the trigeminal nerve. J Orofac Pain. 2013;27(4):293–303.
17. Wolford LM, Rodrigues DB. Autogenous grafts/allografts/conduits for bridging peripheral trigeminal nerve gaps. Atlas Oral Maxillofac Surg Clin North Am. 2011;19(1):91–107.
18. Dodson TB, Kaban LB.Recommendations for management of trigeminal nerve defects based on a critical appraisal of the literature. J Oral Maxillofac Surg. 1997;55(12):1380–6; discus­sion 1387.
19. Meyer RA. Improving quality of life for oral cancer patients. J Oral Maxillofac Surg. 2018;76(3):468.
332
https://t.me/medicina_free
20. Miloro M, Stoner JA.Subjective outcomes following sural nerve harvest. J Oral Maxillofac Surg. 2005;63(8):1150–4.
21. McCormick SU, Buchbinder, McCormick SA, Stark M.Microanatomic analysis of the medial antebrachial nerve as a potential donor nerve in maxillofacial grafting. J Oral Maxillofac Surg. 1994;52(10):1022–5.
22. Shibahara T, etal. Morphologic changes in forearm aps of the oral cavity. J Oral Maxillofac Surg. 2000;58(5):495–9.
23. Kuriakose MA, et al. Sensate radial forearm free aps in tongue reconstruction. Arch Otolaryngol Head Neck Surg. 2001;127(12):1463–6.
24. Schultes G, Gaggl A, Kärcher H.Vascularized transplantation of the long thoracic nerve for sensory reinnervation of the lower lip. Br J Oral Maxillofac Surg. 2000;38(2):138–41.
25. Tanaka K, etal. Bilateral inferior alveolar nerve reconstruction with a vascularized sural nerve graft included in a free bular osteocutaneous ap after segmental mandibulectomy. Head Neck. 2016;38(5):E111–4.
26. Sedaghati T, Jell G, Seifalian AM.Nerve regeneration and bioengineering. Regenerative medi­cine applications in organ transplantation. London: Academic Press; 2014. p.799–810.
27. Chaimanakarn S, Sakdejayont W. Inferior alveolar and lingual nerve microneurosurgery. Mahidol Dental J. 2019;39(1):41–52.
28. Miloro M, Ruckman P III, Kolokythas A.Lingual nerve repair: to graft or not to graft? J Oral Maxillofac Surg. 2015;73(9):1844–50.
29. Zuniga JR. Sensory outcomes after reconstruction of lingual and inferior alveolar nerve discontinuities using processed nerve allograft—a case series. J Oral Maxillofac Surg. 2015;73(4):734–44.
30. Yampolsky A, etal. Efcacy of acellular nerve allografts in trigeminal nerve reconstruction. J Oral Maxillofac Surg. 2017;75(10):2230–4.
31. Akbari M, Miloro M.The inferior alveolar nerve: to graft or not to graft in ablative mandibular resection? J Oral Maxillofac Surg. 2019;77(6):1280–128.
V. A. Manon et al.
Chapter 19
https://t.me/medicina_free
Trigeminal Nerve Reconstruction inMaxillofacial Surgery
RaymondP.Shupak, JeffreyHartgerink, CheukSunEdwinLai, SimonYoung , AlexisM.Linnebur, ZacharyS.Peacock, SrinivasaR.Chandra, AshishPatel, andJamesC.Melville
R. P. Shupak (*) Department of Oral Medicine and Maxillofacial Surgery, Geisinger Commonwealth School of Medicine, Geisinger Health System, Danville, PA, USA e-mail: rshupak@geisinger.edu
J. Hartgerink Chemistry and Bioengineering, Rice University, Houston, TX, USA
Undergraduate Studies, Rice University, Houston, TX, USA e-mail: jdh@rice.edu
C. S. E. Lai Rice University, Houston, TX, USA e-mail: cl95@rice.edu
S. Young · J. C. Melville Department of Oral and Maxillofacial Surgery, The University of Texas Health Science Center at Houston, Houston, TX, USA e-mail: Simon.Young@uth.tmc.edu; James.C.Melville@uth.tmc.edu
A. M. Linnebur Carle Foundation Hospital, Urbana, IL, USA e-mail: alexis.linnebur@carle.com
Z. S. Peacock Oral and Maxillofacial Surgery, Massachusetts General Hospital (MGH), Boston, MA, USA e-mail: zpeacock@partners.org
S. R. Chandra Oral and Maxillofacial Surgery, Oregon Health Sciences School of Dentistry, Portland, OR, USA e-mail: chandrsr@ohsu.edu
A. Patel Oral, Head and Neck Surgery, Head and Neck Surgical Associates, Portland, OR, USA e-mail: Patela@head-neck.com
© The Author(s), under exclusive license to Springer Nature Switzerland AG 2023 J. C. Melville et al. (eds.), Advancements and Innovations in OMFS, ENT, and Facial Plastic Surgery, https://doi.org/10.1007/978-3-031-32099-6_19
333
Соседние файлы в папке @xirurgi_2025